RASAL3 report

Query

Invalid input gene. Please select from the suggestions.

I. Expression across cell types

Cell ontologyData table

Name	Number of supported studies	Average coverage
natural killer cell	27 studies	24% ± 7%	Explore
CD8-positive, alpha-beta T cell	26 studies	22% ± 7%	Explore
T cell	18 studies	21% ± 4%	Explore
CD4-positive, alpha-beta T cell	18 studies	21% ± 5%	Explore
mature NK T cell	15 studies	24% ± 8%	Explore
CD16-positive, CD56-dim natural killer cell, human	13 studies	28% ± 10%	Explore
gamma-delta T cell	12 studies	27% ± 6%	Explore
regulatory T cell	12 studies	20% ± 5%	Explore
CD16-negative, CD56-bright natural killer cell, human	11 studies	27% ± 8%	Explore
mucosal invariant T cell	9 studies	23% ± 5%	Explore
CD8-positive, alpha-beta memory T cell	8 studies	31% ± 8%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	8 studies	25% ± 7%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	21% ± 5%	Explore
effector memory CD8-positive, alpha-beta T cell	6 studies	27% ± 7%	Explore
T follicular helper cell	6 studies	21% ± 3%	Explore
B cell	5 studies	18% ± 4%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	5 studies	21% ± 5%	Explore
memory B cell	5 studies	19% ± 3%	Explore
exhausted T cell	4 studies	35% ± 14%	Explore
effector CD8-positive, alpha-beta T cell	4 studies	20% ± 4%	Explore
lymphocyte	4 studies	21% ± 5%	Explore
innate lymphoid cell	4 studies	22% ± 6%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	24% ± 5%	Explore
microglial cell	4 studies	22% ± 7%	Explore
non-classical monocyte	3 studies	34% ± 6%	Explore
naive B cell	3 studies	18% ± 1%	Explore
effector memory CD4-positive, alpha-beta T cell	3 studies	23% ± 5%	Explore
T-helper 17 cell	3 studies	20% ± 1%	Explore

II. Expression across tissues

sc-RNAseq dataData table

Name	Number of supported studies	Average coverage
peripheral blood	8 studies	21% ± 4%	Explore

Bulk RNAseq dataData table

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	2612.90	578 / 578	95%	9.89	1099 / 1155
thymus	99%	1066.72	647 / 653	95%	13.99	576 / 605
kidney	92%	729.91	82 / 89	88%	9.54	792 / 901
prostate	94%	770.45	231 / 245	81%	4.19	406 / 502
breast	82%	412.73	375 / 459	92%	8.20	1023 / 1118
stomach	86%	524.61	307 / 359	83%	7.78	236 / 286
uterus	81%	374.38	138 / 170	86%	7.30	396 / 459
esophagus	77%	381.84	1116 / 1445	85%	6.09	156 / 183
intestine	77%	1507.17	742 / 966	85%	6.34	449 / 527
adrenal gland	95%	457.25	245 / 258	59%	2.59	136 / 230
liver	83%	383.36	187 / 226	71%	4.51	289 / 406
bladder	71%	656.57	15 / 21	75%	6.25	376 / 504
brain	30%	141.15	805 / 2642	86%	6.20	604 / 705
pancreas	20%	76.32	65 / 328	94%	9.96	167 / 178
skin	35%	121.46	627 / 1809	77%	10.72	362 / 472
lymph node	0%	0	0 / 0	100%	84.94	29 / 29
peripheral blood	100%	7172.00	929 / 929	0%	0	0 / 0
spleen	100%	8855.06	241 / 241	0%	0	0 / 0
adipose	93%	629.17	1121 / 1204	0%	0	0 / 0
tonsil	0%	0	0 / 0	91%	15.18	41 / 45
ovary	21%	79.02	38 / 180	64%	3.38	274 / 430
blood vessel	53%	304.12	703 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	23%	1.54	18 / 80
heart	21%	81.47	182 / 861	0%	0	0 / 0
muscle	4%	11.00	30 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1